You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 6, June 1979 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIAL
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (99)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Current Arterial Prostheses

Experimental Evaluation by Implantation in the Carotid and Circumflex Coronary Arteries of the Dog

Lester R. Sauvage, MD; Mark W. Walker, MS; Knute Berger, MD; Stephen B. Robel, MS; Michael M. Lischko, MS; Stanley G. Yates, MS; Gordon A. Logan, MD

Arch Surg. 1979;114(6):687-691.


Abstract

• Five types of 4-mm diameter arterial prostheses (three Dacron, one expanded Teflon, one preserved umbilical vein) were studied in the dog to assess graft thrombogenicity. Separate experiments involving six hours of controlled blood flow, one-week carotid implantation, and aortocoronary implantation were performed. In general, graft thrombogenicity derived from controlled flow study was more predictive of a graft's long-term implantation success than were one-week implantation results. In order of increasing thrombogenicity, we ranked grafts studied as follows: noncrimped Dacron, expanded Teflon, crimped Dacron, umbilical vein. Results of 19 experimental left coronary artery implantations using Dacron or Teflon prostheses are reported that indicate grafts with low measured thrombogenicity are most likely to succeed in this site. Data presented in this report suggest there is reason to evaluate noncrimped, kinkresistant, porous Dacron grafts for use both in the left coronary artery and below the knee when there is compelling clinical indication and no autogenous vessels are available.

(Arch Surg 114:687-691, 1979)



Author Affiliations

From the Reconstructive Cardiovascular Research Center International (Drs Sauvage, Berger; Messrs Walker, Lischko, and Yates) and The Heart Center (Dr Logan) of the Providence Medical Center; the Department of Surgery, School of Medicine, University of Washington (Dr Sauvage); and the Department of Mechanical Engineering, Seattle (Wash) University (Mr Robel).


Footnotes

Accepted for publication Nov 9, 1978.

Reprint requests to the Reconstructive Cardiovascular Research Center International, 528-18th Ave, Seattle, WA 98122 (Dr Sauvage).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Popliteal Angioplasty as an Adjunct to Above-the-Knee Synthetic Femoropopliteal Bypass: Comparison of Long-Term Results with Below-the-Knee Bypass
Onohara et al.
VASC ENDOVASCULAR SURG 1999;33:151-155.
ABSTRACT  

Risk-Benefit Analysis of Treatment Options for Patients With Critical Limb Ischemia
Harris
PERSPECT VASC SURG ENDOVASC THER 1995;8:14-19.
 

ePTFE Grafts and a Venous Boot
Tyrrell and Wolfe
PERSPECT VASC SURG ENDOVASC THER 1993;6:57-66.
 

Hemodynamics of In Situ Saphenous Vein Arterial Bypass
Bandyk et al.
Arch Surg 1988;123:477-482.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.